News
Australian GP named in global list of elite researchers
Professor Paul Glasziou has been recognised as one of the world’s most cited researchers in 2019.
Professor Paul Glasziou published multiple papers in 2019 ranked in the top 1% in citations for their field.
The 2019 Highly Cited Researchers list by the Web of Science Group identifies scientists who have demonstrated significant research influence among their peers.
Professor Paul Glasziou joins 23 Nobel laureates in being recognised as having authored multiple papers ranked in the top 1% in citations for their field.
Professor Glasziou is also the Director of Bond University’s Institute for Evidence-Based Healthcare, which is described as a ‘world-leading research centre in the realm of evidence-based practice’.
‘Under Professor Glasziou’s leadership over the past 10 years, the Institute has developed an international reputation for excellence in its field,’ Professor Keitha Dunstan, Bond University Deputy Vice Chancellor (Academic), said.
Professor Glasziou’s latest paper, ‘The Burden of Cancer Overdiagnosis in Australia’, is due to be published soon.
‘We aim to improve communication between clinicians and researchers, and provide a clearer understanding of the causes of, and solutions to, gaps between research evidence and its application in practice,’ he said.
‘Our primary focuses include promoting effective non-pharmaceutical interventions for patients, ways to reduce the over-use of antibiotics to reduce antimicrobial resistance, and reducing overdiagnosis.
‘All these are important to better and more sustainable healthcare.’
The latest honour comes after Professor Glasziou was the recent recipient of a National Health and Medical Research Council (NHMRC) Investigator Grant for his research project, ‘Neglected problems in healthcare’, which focuses on four prominent areas in healthcare:
- Overdiagnosis and overtreatment
- Non-drug interventions
- Antibiotic overuse and resistance
- Waste in research
This project is supported by work on the development of methods, tools, implementation and capacity, and grew out of Professor Glasziou’s own clinical work in general practice.
‘I found it difficult to use effective non-drug treatments [in general practice] because they are often poorly described in the original trials,’ he
previously told newsGP.
‘I was frustrated by the ever-expanding definitions of our diseases, even when there is often poor evidence to justify us treating the lower risk patients included in the expanded definitions, such as chronic kidney disease, gestational diabetes, and PCOS [polycystic ovary syndrome].’
Log in below to join the conversation.
antimicrobial resistance general practice research non-pharmaceutical intervention overdiagnosis sustainable healthcare Web of Science Group
newsGP weekly poll
Is it becoming more difficult to access specialist psychiatric support for patients with complex mental presentations?